Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $3.82 Million - $4.9 Million
-21,536 Reduced 82.02%
4,720 $901,000
Q2 2022

Aug 11, 2022

BUY
$181.58 - $368.0 $4.02 Million - $8.14 Million
22,117 Added 534.36%
26,256 $4.84 Million
Q1 2022

May 12, 2022

SELL
$303.87 - $423.8 $1.07 Million - $1.5 Million
-3,537 Reduced 46.08%
4,139 $1.45 Million
Q4 2021

Feb 09, 2022

SELL
$347.28 - $421.83 $171,556 - $208,384
-494 Reduced 6.05%
7,676 $2.92 Million
Q3 2021

Nov 10, 2021

BUY
$405.61 - $524.84 $3.05 Million - $3.95 Million
7,531 Added 1178.56%
8,170 $3.31 Million
Q2 2021

Aug 12, 2021

SELL
$372.84 - $481.5 $2.4 Million - $3.1 Million
-6,434 Reduced 90.97%
639 $302,000
Q1 2021

May 13, 2021

BUY
$361.28 - $504.76 $2.22 Million - $3.1 Million
6,138 Added 656.47%
7,073 $2.72 Million
Q4 2020

Feb 12, 2021

SELL
$292.7 - $370.96 $1.49 Million - $1.88 Million
-5,077 Reduced 84.45%
935 $346,000
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $1.24 Million - $1.84 Million
4,600 Added 325.78%
6,012 $1.86 Million
Q2 2020

Aug 12, 2020

SELL
$256.46 - $373.01 $540,874 - $786,678
-2,109 Reduced 59.9%
1,412 $523,000
Q1 2020

May 13, 2020

BUY
$209.2 - $335.53 $365,472 - $586,170
1,747 Added 98.48%
3,521 $962,000
Q4 2019

Feb 12, 2020

SELL
$288.29 - $335.49 $845,842 - $984,327
-2,934 Reduced 62.32%
1,774 $589,000
Q3 2019

Nov 12, 2019

BUY
$266.84 - $378.23 $1.26 Million - $1.78 Million
4,708 New
4,708 $1.43 Million
Q2 2019

Aug 12, 2019

SELL
$300.59 - $368.15 $527,535 - $646,103
-1,755 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$272.57 - $321.18 $205,790 - $242,490
755 Added 75.5%
1,755 $545,000
Q4 2018

Feb 11, 2019

BUY
$272.46 - $366.54 $272,460 - $366,540
1,000 New
1,000 $300,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.